Etoposide plus idarubicin and prednisone in refractory or relapsed multiple myeloma. A phase II study.
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004341:Drug Evaluation; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use
D005047:Etoposide; D011241:Prednisone; D015255:Idarubicin